Treatment Varies Widely in Chronic Myeloid Leukemia
FDA Simplifies Patient Access to Investigational Drugs
Advances in Genetics and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders
Reference Sheet
Chemotherapeutic Agents and Their Uses, Dosages, and Toxicities
